Skip to content
Screener

Haemonetics HAE Intangibles (Net)

Intangibles (Net) at other companies

Abbott logo
AbbottABT
$17.21B+2,081%
TFX
TeleflexTFX
$1.45B-33.7%
Medtronic logo
MedtronicMDT
$10.15B-13.0%
LivaNova logo
LivaNovaLIVN
$217M-9.3%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$4.66M+10.6%
ITG
Integer HoldingsITGR
$716.05M-6.5%

Other financials

Income statement

See full
Revenue$339.4M+5.6%
Gross profit$202.8M+5.5%
Operating income$57.5M+6.7%
Net income$33.0M-3.0%
EPS (diluted)$0.72+2.9%

Balance sheet

See full
Cash & equivalents$223.4M-23.7%
Total debt$1.2B-4.1%
Total equity$837.1M-5.1%
Total assets$2.4B-3.9%

Cash flow

See full
Operating cash flow$52.3M+201%
CapEx$7.9M+111%
Free cash flow$44.4M+226%

Valuation

See full
Market cap$3.87B+6.3%
Enterprise value$4.82B+5.4%
P/E25.7×-10.5×
P/S2.9×+0.2×

Profitability

See full
Gross margin59%+2.1pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin21.5%+7.5pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.4×0.0×
Current ratio3.1×+1.4×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The source filing: Haemonetics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:09 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000313143-26-000120
June 27, 2026Gross Carrying Amount / (Dollars in Thousands)Accumulated Amortization / (Dollars in Thousands)Net Carrying Amount / (Dollars in Thousands)Weighted Average Remaining Life (Years)
Customer contracts and related relationships129,60177,47552,12611.1
Capitalized software97,63683,74113,8953.1
Patents and other7,4224,7632,6595.3
Trade names14,6087,4287,18010.2
Total$803,296$374,828$428,468
Non-amortizable:
In-process software development$6,044
Total$6,044

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Haemonetics's intangibles (net)?
Haemonetics (HAE) reported intangibles (net) of $428.47M in Q2 2026.
How has Haemonetics's intangibles (net) changed year-over-year?
Haemonetics's intangibles (net) decreased by 4.5% year-over-year, from $448.85M to $428.47M.
What is the long-term trend for Haemonetics's intangibles (net)?
Over 5 years (2021 to 2026), Haemonetics's intangibles (net) has grown at a 3.9% compound annual growth rate (CAGR), from $365.48M to $441.75M.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.

Ask your AI about Haemonetics's intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude